Case Report
Published on 26 Aug 2022
Recurrent paraganglioma of the vulva: A rare case report and review of the literature
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.961666
- 1,734 views
Type at least 3 characters
906 articles
Articles
Original Research
Published on 26 Aug 2022
Integrated analysis of the M2 macrophage-related signature associated with prognosis in ovarian cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.986885
- 3,113 views
- 6 citations
Original Research
Published on 25 Aug 2022
Misdiagnosed appendiceal mucinous neoplasms and primary ovarian mucinous tumors present with different pre- and intraoperative characteristics
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.966844
- 1,703 views
- 1 citation
Clinical Trial
Published on 25 Aug 2022
Cervical cancer screening in high-altitude areas in China: A large cross-section study of 25,173 women in northern Tibet
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.841547
- 2,070 views
Original Research
Published on 23 Aug 2022
Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.954430
- 4,790 views
- 2 citations
Review
Published on 22 Aug 2022
Importance of the endometrial immune environment in endometrial cancer and associated therapies
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.975201
- 5,362 views
- 9 citations
Original Research
Published on 18 Aug 2022
What predicts the clinical benefits of PARP inhibitors in platinum-sensitive recurrent ovarian cancer: A real-world single-center retrospective cohort study from China
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.955124
- 3,993 views
- 7 citations
Original Research
Published on 18 Aug 2022
The top 100 most cited papers on endometrial carcinoma: A bibliometric analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.987980
- 3,189 views
- 6 citations
Review
Published on 18 Aug 2022
The evolving role of morphology in endometrial cancer diagnostics: From histopathology and molecular testing towards integrative data analysis by deep learning
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.928977
- 7,477 views
- 6 citations
Original Research
Published on 18 Aug 2022
Radiomics feature as a preoperative predictive of lymphovascular invasion in early-stage endometrial cancer: A multicenter study
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.966529
- 2,366 views
- 10 citations
Review
Published on 18 Aug 2022
Recommendations for the prevention, screening, diagnosis, staging, and management of cervical cancer in areas with limited resources: Report from the International Gynecological Cancer Society consensus meeting
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.928560
- 3,506 views
- 5 citations
Original Research
Published on 17 Aug 2022
Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.942960
- 3,182 views
- 12 citations
Case Report
Published on 16 Aug 2022
Case Report: A case of uterine leiomyosarcoma metastasized to the vena cava, excised with the aid of preoperative CT three-dimensional imaging
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.905857
- 2,125 views
- 2 citations
Original Research
Published on 12 Aug 2022
Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.935628
- 2,160 views
- 2 citations
Original Research
Published on 11 Aug 2022
A new technique for performing interstitial implants for gynecologic malignancies using transvaginal ultrasound guidance
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.858620
- 1,768 views
- 2 citations
Original Research
Published on 10 Aug 2022
OCT4 induces EMT and promotes ovarian cancer progression by regulating the PI3K/AKT/mTOR pathway
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.876257
- 4,396 views
- 16 citations